查找临床试验
已按「脊髓性肌萎缩症」检索，对应国际通用词 spinal muscular atrophy
共找到 10 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:24，每 5 分钟自动同步正在招募III 期中国有中心NCT07221669
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
United States、Australia、Brazil、China、Japan
年龄 0 Days – 42 Days
Biogen
正在招募I 期 / II 期中国有中心NCT05824169
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients
China
年龄 0 Months – 6 Months
GeneCradle Inc
正在招募不适用中国有中心NCT03217578
Neonatal Spinal Muscular Atrophy (SMA) Screening
Taiwan
年龄 0 Weeks – 2 Weeks
Kaohsiung Medical University Chung-Ho Memorial Hospital
正在招募不适用中国有中心NCT04174157
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
United States、Greece、Ireland、Israel、Japan 等 11 国
年龄 不限 – 不限
Novartis Pharmaceuticals
正在招募I 期 / II 期中国有中心NCT06421831
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients
China
年龄 2 Years – 不限
GeneCradle Inc
正在招募I 期 / II 期中国有中心NCT07190300
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
United States、Australia、Brazil、Canada、China 等 12 国
年龄 18 Years – 不限
Novartis Pharmaceuticals
正在招募III 期中国有中心NCT06971094
Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III
China
年龄 2 Years – 12 Years
GeneCradle Inc
正在招募I 期 / II 期中国有中心NCT07554924
A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
China
年龄 不限 – 180 Days
Lanyue Biotech (Hangzhou) Co., Ltd.
正在招募I 期 / II 期中国有中心NCT07336446
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
United States、Australia、Canada、China、Japan 等 8 国
年龄 18 Years – 不限
AstraZeneca
正在招募不适用中国有中心NCT04010604
A Registered Cohort Study on SMA
China
年龄 1 Week – 70 Years
Wan-Jin Chen